Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Procuritas in connection with the sale of Ouriginal Group
Mandate

Vinge has advised Procuritas in connection with the sale of Ouriginal Group

January 07, 2022 EU, Competition and Regulatory IT, Telecommunications and Outsourcing M&A Intellectual Property

Vinge has advised Procuritas, the private equity investor focused on investing in and growing Nordic mid-market companies, in connection with the sale of Ouriginal Group to Turnitin LLC, a global leader in academic integrity and education software.

Ouriginal, a company formed from the union of Urkund and PlagScan, has over three decades of experience in combining text-matching with writing-style analysis to promote academic integrity and prevent plagiarism in schools and universities.

Vinge’s team consisted of Jonas Johansson, Karl Klackenberg and Ellinor Wargenbrant (M&A), Mathilda Persson (IT), Tobias Kempas (IP), Sebastian Örndahl and Victoria Fredén (Competition) and Viktoria Owetz Leyva (VDR).

Related

Vinge advises Right Side Group, a portfolio company of Alder, in connection with the acquisition of Brandkonsultbyrån i Sverige

 Brandkonsultbyrån in Sweden is a technical consultant specialising in structural fire protection, evacuation safety and risk management. The acquisition strengthens the group’s position as a leading player in fire, risk and safety in the Nordic region.
April 17, 2026

Vinge advises Vidia Climate Fund I in connection with the acquisition and acquisition financing of ABEKA El & Kraftanläggningar AB

 Vinge has acted as legal adviser to Vidia Climate Fund I in connection with the acquisition and acquisition financing of ABEKA El & Kraftanläggningar AB from Bravida and certain minority shareholders. ABEKA El & Kraftanläggningar AB is a highly specialized electrical grid services and project management provider.
April 17, 2026

Vinge adviser in the sale of SAGA Diagnostics

 Vinge acted as legal adviser relating to Swedish law in connection with the sale of SAGA Diagnostics to Roche’s subsidiary Foundation Medicine.
April 16, 2026